CD4 and HIV infectious disease: There was statistically significant difference between TMP/SMX-treatment group and non-treatment group in variables such as admission in stage 3 of HIV infection, viral load and CD4 T-cell count at admission, number of days of CBC testing during follow-up, and ART at hospital admission (Table 1).